Drug recall · August 14, 2024
Methotrexate Tablets recall
Why: Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1
- Lots / codes
Lot # BB29124, Exp. 02/28/2026
- Quantity
- 12,624 bottles
- Company
- Amneal Pharmaceuticals, LLC, Bridgewater, NJ
- Distribution
- Nationwide in the USA
- Initiated
- August 1, 2024 · Voluntary: Firm initiated
- Classified
- August 8, 2024
- Reported
- August 14, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Methotrexate
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.